APA
Gill S. K., Xu H., Kirchhoff P. D., Cierpicki T., Turbiak A. J., Wan B., Zhang N., Peng K., Franzblau S. G., Garcia G. A. & Showalter H. D. H. (20120717). Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases. : Journal of medicinal chemistry.
Chicago
Gill Sumandeep K, Xu Hao, Kirchhoff Paul D, Cierpicki Tomasz, Turbiak Anjanette J, Wan Baojie, Zhang Nan, Peng Kuan-Wei, Franzblau Scott G, Garcia George A and Showalter H D Hollis. 20120717. Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases. : Journal of medicinal chemistry.
Harvard
Gill S. K., Xu H., Kirchhoff P. D., Cierpicki T., Turbiak A. J., Wan B., Zhang N., Peng K., Franzblau S. G., Garcia G. A. and Showalter H. D. H. (20120717). Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases. : Journal of medicinal chemistry.
MLA
Gill Sumandeep K, Xu Hao, Kirchhoff Paul D, Cierpicki Tomasz, Turbiak Anjanette J, Wan Baojie, Zhang Nan, Peng Kuan-Wei, Franzblau Scott G, Garcia George A and Showalter H D Hollis. Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases. : Journal of medicinal chemistry. 20120717.